Some useful progress with phase III trial:
http://www.biocentury.com/dailynews/clinical/2012-05-11/takedas-vedolizumab-meets-crohns-endpoint
http://www.biocentury.com/dailynews/clinical/2012-05-11/takedas-vedolizumab-meets-crohns-endpoint